Active Comparator vaccine

BIOLOGICAL5 trials

Sponsors

CSPC Megalith Biopharmaceutical Co.,Ltd., Sinovac Biotech Co., Ltd

Conditions

Epidemic MeningitisHerpes ZosterMeningococcal Vaccines

Phase 2

Immunogenicity and Safety of SYS6017 in the Participants Aged 40 Years and Above

Not yet recruitingNCT07354659

CSPC Megalith Biopharmaceutical Co.,Ltd.Herpes Zoster

Start: 2026-01-10End: 2027-05-31Target: 800Updated: 2026-01-21

Phase 3

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months

RecruitingNCT07505836

Sinovac Biotech Co., LtdEpidemic Meningitis, Meningococcal Vaccines

Start: 2026-03-22End: 2027-01-01Target: 1040Updated: 2026-08-10

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months

RecruitingNCT07505810

Sinovac Biotech Co., LtdEpidemic Meningitis, Meningococcal Vaccines

Start: 2026-03-25End: 2028-01-01Target: 880Updated: 2026-08-10

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years

Active, not recruitingNCT07505888

Sinovac Biotech Co., LtdEpidemic Meningitis, Meningococcal Vaccines

Start: 2026-03-22End: 2026-11-01Target: 660Updated: 2026-08-10

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months

RecruitingNCT07505823

Sinovac Biotech Co., LtdEpidemic Meningitis, Meningococcal Vaccines

Start: 2026-03-22End: 2028-01-01Target: 1040Updated: 2026-08-10